GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr | ₹6.28 Cr |
What is the latest Sundry Debtors ratio of GENNEX LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹9.42 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹7.66 Cr |
Mar2020 | ₹6.28 Cr |
How is Sundry Debtors of GENNEX LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | 89.14 | |
Mar2023 | ₹9.42 Cr | -16.76 | |
Mar2022 | ₹11 Cr | 47.75 | |
Mar2021 | ₹7.66 Cr | 21.93 | |
Mar2020 | ₹6.28 Cr | - |
Compare Sundry Debtors of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹271.7 Cr | -8.3% | -3.8% | -51.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,682.0 Cr | -2.5% | -0.2% | -15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,985.0 Cr | -5.9% | -6.9% | 5.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,862.0 Cr | -1.9% | 0.7% | 3.9% | Stock Analytics | |
CIPLA | ₹121,294.0 Cr | -2.6% | -6.4% | -8.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,132.0 Cr | -5.6% | -2.2% | -6.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -8.3% |
-3.8% |
-51.6% |
SENSEX | -2.2% |
0.6% |
-5.8% |
You may also like the below Video Courses